DalsnaFinance › Analyst accuracy › All targets
Every price target we have verified from published news, newest first: 77 targets from BMO Capital Markets. Each one shows the article it came from and links to its full entry, and is judged on the close on the date it comes due. “At” is the closing price nearest the day the target was reported, the price we score it from; it is not an earlier target.
Showing targets from BMO Capital Markets only. All targets BMO Capital Markets’s record →
BMO Capital raised its price target for Netskope to $18.00
BMO Capital raised its price target on Walmart Inc. shares to $136 from $126 on Monday
BMO raises Celanese stock price target to $58 on cost cuts
BMO Capital lowered its price target for Texas Roadhouse to $190 while maintaining a Market Perform rating
BMO Capital reiterated a Market Perform rating on Lyft Inc. (NASDAQ:LYFT) shares with a $23.00 price target.
BMO Capital lowered its price target on Booking Holdings (NASDAQ:BKNG) to $245 from $250
BMO Capital raised its price target on Equinix stock ... to $1,250 from an undisclosed prior level while maintaining an Outperform rating.
BMO Capital raised its price target on Eli Lilly shares (NYSE:LLY) to $1,650 from $1,400 while maintaining an Outperform rating.
BMO Capital raised its price target on Atlassian Corporation (NASDAQ:TEAM) to $225 from $170 while maintaining an Outperform rating.
BMO Capital raised its price target on HubSpot Inc (NYSE:HUBS) to $255 from $250 while maintaining a Market Perform rating.
BMO Capital lowered its price target on GE Vernova shares (NYSE:GEV) to $1,200 from $1,250
This performance prompted BMO Capital to increase its price target to $610, while KeyBanc raised it to $630 citing Azure's potential to exceed 50% growth.
BMO Capital maintained an Outperform rating with a $192 price target
lowered its price target on Fair Isaac stock (NYSE:FICO) to $897 from a previous level
with an outperform rating and a price target of $50.00.
The bank raised its target to $265 from $230 but kept its Market Perform rating.
BMO Capital lowered its price target on Crown Castle stock to $91 from $93
BMO Capital upgraded Ionis Pharmaceuticals (NASDAQ:IONS) from Market Perform to Outperform on Wednesday and raised its price target to $66 from $54.
Goldman Sachs stock: BMO cuts target for Goldman Sachs stock to USD 950.00
to $87.00 from an undisclosed prior level while maintaining an Outperform rating.
to $600 from $515 while maintaining an Outperform rating.
BMO Capital raised its price target on Disc Medicine (NASDAQ:IRON) to $120 from $100
BMO Capital raised its price target on NiSource Inc. (NYSE:NI) to $48.00 from $45.00
lowered its price target on CenterPoint Energy (NYSE:CNP) to $45 from $48 while maintaining an Outperform rating
BMO Capital lowered its price target on Manpower Inc. (NYSE:MAN) to $58 from $63
BMO Capital Markets cut their target price on shares of Amgen from $450.00 to $415.00 and set a "market perform" rating for the company in a research report on Monday, October 12th.
Mizuho bumped its target to $165 with an Outperform, and BMO took theirs to $170, also with an Outperform rating.
BMO Capital raised its price target on Diamondback Energy to $224 from $215 and kept an Outperform rating, fitting into an overweight Street view with mean targets around the mid-$230s.
to $160 from $190 while maintaining a Market Perform rating
Investing.com - BMO Capital lowered its price target on Netflix stock to $125 from $135 while maintaining an Outperform rating.
Visa Stock Hits Fresh Record High – BMO Raises Price Target To $425 Ahead Of Earnings
BMO Capital cut its price target on American Airlines from $19 to $15.50 while maintaining a Market Perform rating, citing rising jet fuel costs tied to ongoing Middle East conflict, partly offset by still-solid travel demand and some pricing power.
BMO Capital reiterated a Market Perform rating on Murphy Oil Corp. (NYSE:MUR) with a $40.00 price target.
BMO Capital reiterated a Market Perform rating on Occidental Petroleum with a $68.00 price target
BMO trimmed its JetBlue target to $5.25, warning that jet fuel tied to Middle East conflict is squeezing margins despite resilient travel demand and modest fare hikes.
AMGN Maintains by BMO Capital -- Price Target Lowered to $415
raised its price target on Biogen Inc. (NASDAQ:BIIB) to $220 from $218
BMO Capital reiterated an Outperform stock rating and $190.00 price target on Constellation Brands (NYSE:STZ) Thursday.
BMO Capital raised its price target on Black Hills Corp shares (NYSE:BKH) to $86 from $83
BMO Capital reiterated an Outperform rating and $36.00 price target on Trevi Therapeutics ([NASDAQ:TRVI](https://www.investing.com/equities/trevi-therapeutics-inc)) shares following a competitor's clinical trial failure.
BMO Capital downgraded RXO, Inc. (NYSE:RXO) to Market Perform from Outperform and lowered its price target to $30.25 from $35.00.
BMO Capital downgraded PTC Inc. (NASDAQ:PTC) to Market Perform from Outperform on Tuesday while raising its price target to $205 from $164.
reiterated her "Underperform" rating and trimmed her price target from $30 to $25.
BMO cuts target for Portland General Electric stock to USD 47
BMO Capital initiated coverage on nVent Electric (NYSE:NVT) with an outperform rating and a price target of $212.00.
BMO Capital raised its price target on Accenture plc (NYSE:ACN) to $235 from $200 while maintaining a Market Perform rating on the stock.
BMO Capital reiterated a Market Perform rating on PBF Energy ([NYSE:PBF](https://www.investing.com/equities/pbf-energy-inc)) with an $80.00 price target.
to $220 from $225 while maintaining a Market Perform rating
The new target represents roughly 9% upside from the current price of $183.72
BMO Capital reiterated an Outperform rating and $600.00 price target on Vertex Pharmaceuticals Inc.
Retracted targets, ones we found we had misreported, are not listed here and count toward nothing; each firm's row on the analyst accuracy page lists its own under "Retracted". These are facts about what each firm published, not recommendations from Dalsna Finance.
Full methodology: how targets are collected, scored, ranked and corrected, what each field means, and how to cite the data.